Question: Will there be a shortage of drugs for Hepatitis B or C due to COVID-19?

Answer passage (source: CDC):
page_title: What to Know About Liver Disease and COVID-19
section_headers: Are people with hepatitis B virus or hepatitis C at higher risk for COVID-19 than other people?
section_content: Currently, we have no information about whether people with hepatitis B or
hepatitis C are at increased risk for getting COVID-19 or having severe
COVID-19. However, based on available information and clinical expertise,
older adults and people of any age who have serious underlying medical
conditions, including people with liver disease, might be at higher risk for
severe illness from COVID-19, particularly if the underlying medical
conditions are not well controlled.

Reviewer feedback on this answer:
The question is asking about drug shortages for hepatitis but this response is only talking about whether people with hepatitis are at advanced risk. This is answering the wrong question
This answer is irrelevant to the question. The question is asking about shortage of drugs for Hepatitis B or C during Covid-19 outbreak and the answer provides information the the increased risk of Covid-19 in people with hepatitis B or hepatitis C.

Reviewer ratings:
Bad
Bad

Answer passage (source: CDC):
page_title: What to Know About Liver Disease and COVID-19
section_headers: Are shortages of hepatitis B or hepatitis C medicine expected?
section_content: No drug shortages or anticipated problems with medicine used to treat
hepatitis B or hepatitis C have been identified to date.
The U.S. Food and Drug Administration (FDA) is closely monitoring the drug
supply chain because the COVID-19 outbreak has the potential to disrupt the
supply of medical and pharmaceutical products in the United States.
Learn more about the FDA’s response to COVID-19external
icon and information on drug shortagesexternal
icon.

Reviewer feedback on this answer:
This answers the question directly and immediately. It also provides relevant link to information about drug shortages so this sufficiently answers the question
This information is a direct answer to the question. It provides information on potential drug shortage and anticipated problems for hepatitis B or hepatitis C treatment during Covid-19 outbreak.

Reviewer ratings:
Excellent
Excellent

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Patients with Liver Disease
Should people with COVID-19 and increased ALT or AST be tested for viral hepatitis?
section_content: Yes, for your COVID-19 patients with risk factors for viral hepatitis and
elevated hepatic enzymes, consider testing them for hepatitis A virus,
hepatitis B virus, and hepatitis C virus infections. However, elevated alanine
aminotransferase (ALT) or aspartate aminotransferase (AST) may also be
associated with COVID-19 alone and indicate greater severity of illness. For
more information, review CDC’s Interim Clinical Guidance for Management of
Patients with Confirmed Coronavirus Disease
(COVID-19)

Reviewer feedback on this answer:
This answer does not answer the question about drug shortage for hepatitis B or C during Covid-19. Instead, this information gives recommendation to test Covid-19 positive patients for hepatitis A, hepatitis B and hepatitis C virus infections when elevated ALT or AST is found in patients with Covid-19.
This is talking about getting tested for hepatitis which has nothing to do with the hepatitis drug shortages that is being asked about in the question

Reviewer ratings:
Bad
Bad